Liliana Garcia
Physician Assistant · McAllen, TXNPI 1841845856
Payments from drug & device makers
Across 154 payments — averaging $35.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$2K
- Novo Nordisk$1K
- Lilly USA, LLC$402
- Bayer$283
- Medtronic$271
- Amgen$268
- plus $1K from 14 others
What the payments were for
- Travel & lodging$1,12221%
- Food & beverage$4,27179%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $1,647 |
| Novo Nordisk | 54 | $1,035 |
| Lilly USA, LLC | 12 | $402 |
| Bayer | 10 | $283 |
| Medtronic | 2 | $271 |
| Amgen | 9 | $268 |
| Intuity Medical Inc | 6 | $259 |
| Corcept Therapeutics | 4 | $203 |
| Xeris Pharmaceuticals, Inc. | 10 | $176 |
| Sanofi-aventis U.S. LLC | 11 | $176 |
| Tandem Diabetes Care, Inc. | 4 | $168 |
| Dexcom, Inc. | 9 | $156 |
| Rhythm Pharmaceuticals, Inc. | 1 | $125 |
| Boehringer Ingelheim | 3 | $59 |
| Insulet Corporation | 3 | $46 |
| Antares Pharma, Inc. | 3 | $46 |
| Abbott | 2 | $29 |
| Amarin Pharma, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$271
- JARDIANCE$249
- REZDIFFRA$150
- Repatha$125
- t:slim X2 Insulin Pump with Control-IQ$122
- Korlym$120
- Wegovy$115
- Kerendia$115
- RYBELSUS$103
How this compares
$5,393 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 379 | $550,790 |
| MounjaroTirzepatide | 308 | $455,289 |
| JardianceEmpagliflozin | 203 | $249,687 |
| TrulicityDulaglutide | 93 | $149,219 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 91 | $102,866 |
| KerendiaFinerenone | 100 | $92,211 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 72 | $70,024 |
| FarxigaDapagliflozin Propanediol | 60 | $62,343 |
| Tresiba Flextouch U-100Insulin Degludec | 119 | $61,226 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 48 | $55,194 |
| VascepaIcosapent Ethyl | 84 | $48,018 |
| RybelsusSemaglutide | 27 | $41,270 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $33,437 |
| Tresiba Flextouch U-200Insulin Degludec | 50 | $32,928 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 50 | $27,978 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Baqsimi | $402 | $616,528427 claims |
| Novo NordiskOzempic, Rybelsus | $1,035 | $592,060406 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $59 | $369,406314 claims |
| BayerKerendia | $283 | $92,211100 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $176 | $13,11516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in McAllen
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.